New artificial tear containing hyaluronic acid, low-dose hydrocortisone shows promise in DED

Prolonged use of the new artificial tear solution containing hyaluronic acid (HA) and low-dose hydrocortisone is beneficial, even in the initial stages of DED, according to a study. In this randomized, controlled, double-masked study, patients who had been experiencing DED symptoms for ≥6 months underwent an initial 7-day treatment with...